Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Ann Tsukamoto Insider Profile
4 Followers
Ann Tsukamoto, EVP, Research and Development at Microbot Medical, holds 736.52K shares in Microbot Medical (Ticker: MBOT).
Ann Tsukamoto Microbot Medical (MBOT)EVP, Research and Development
Microbot Medical (MBOT)
EVP, Research and Development
Ranked #29,824 out of 98,909 Corporate Insiders
Profitable Transactions
2 out of 3 Profitable Transactions
Average Return
+15.80%
Average return per transaction
Time Frame
Compare to
Insider Roles
EVP, Research and Development
Roles that Ann Tsukamoto holds in companies
Most Profitable Insider Trade
The most profitable trade made by Ann Tsukamoto
Ann Tsukamoto's Trading History
List of latest transactions for each holding click on a transaction to see Ann Tsukamoto's performance on stock
You May Also Like
Ann Tsukamoto insider profile FAQ
What is the percentage of profitable transactions made by Ann Tsukamoto?
The percentage of profitable transactions made by Ann Tsukamoto is 67%.
What is the average return per transaction made by Ann Tsukamoto?
The average return per transaction made by Ann Tsukamoto is 15.80%.
What stocks does Ann Tsukamoto hold?
Ann Tsukamoto holds: MBOT stocks.
What was Ann Tsukamoto’s latest transaction?
Ann Tsukamoto latest transaction was an Uninformative Sell of $22.46K.
What was Ann Tsukamoto's most profitable transaction?
Ann Tsukamoto’s most profitable transaction was an Informative Sell of MBOT stock on May 20, 2011. The return on the trade was 88.50%.
What is Ann Tsukamoto's role in Microbot Medical?
Ann Tsukamoto's role in Microbot Medical is EVP, Research and Development.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.